Perrigo Investor Urges Company to Refocus Core Biz

Sep 12, 2016

Wall Street Journal

Starboard Value LP, which has about a 4.6% stake in Perrigo Co., is urging the drug company to refocus on its core business.

According to a WSJ article, the shareholder sent Perrigo a letter criticizing the company for not living up to performance targets it set while avoiding a $26 billion takeover offer last year from Mylan. Starboard said Perrigo management has been distracted by the merger fight.

Read the full WSJ story

Show Comments
Hide Comments

Join the discussion

We welcome your thoughtful comments.
All comments will display your user name.

Want to participate in the discussion?

Register for free

Log in for complete access.


No one has commented on this page yet.

RSS feed for comments on this page | RSS feed for all comments